Explore Tools Publish Peer Review CV+

/A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Articles (20)

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.